Dapsone (4-4′-diaminodiphenylsulfone) is commonly used for Pneumocystis jirovecii pneumonia (PCP) prophylaxis in immunocompromised patients. Oxidant hemolysis is a known complication of dapsone ...

To manage patients’ hemolysis, 68% (n = 13) underwent a dose increase of pegcetacoplan from twice weekly to 1080 mg every 3 days. This approach reportedly benefited 6 patients’ hemolytic outcomes.

Hemolysis was the most commonly cited cause of transfusion-associated death during the 1976–1985 period 10 but has become one of the least common fatal complications of transfusion, with an ...

Radiation Research, Vol. 37, No. 3 (Mar., 1969), pp. 551-566 (16 pages) Human bank blood erythrocytes were given hemolyzing (16 to 50 kR) exposures of 60 Co gamma rays, suspended in various media, and ...

The pathological changes in the kidneys following intravascular hemolysis are described by a number of authors, 30–32 but the most complete description of the sequence of events is given by Ayer ...

Clinical use of the DAT The DAT is useful in differentiating immune-mediated hemolysis from hemolysis caused by other factors (Box 1). It is important to note that a small but significant number of ...

The more nearly spherical are erythrocytes, the greater is their susceptibility to hemolysis by swelling in hypotonic solutions. There has been no satisfactory explanation, however, for the increased ...

Heme drives hemolysis-induced susceptibility to infection via disruption of phagocyte functions. Nature Immunology, 2016; DOI: 10.1038/ni.3590 ...

Head-to-head exploratory cohort of a Phase 3 trial showed first-in-class poze-cemdi combination treatment helped patients achieve and maintain greater disease control, as measured by lactate ...